+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis



Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis



Gastroenterology 99(1): 181-186



Antinuclear antibodies giving a perinuclear fluorescence and directed to a 200-kilodalton polypeptide of the nuclear envelope have been described in primary biliary cirrhosis. The purpose of this study, based on a series of 150 patients with primary biliary cirrhosis, was to ascertain the prevalence of these antibodies and to compare patients with and without these antibodies. Antinuclear antibodies giving a perinuclear fluorescence were demonstrated in 43 of the 150 patients (29%); antibodies directed to the 200-kilodalton polypeptide of the nuclear envelope were found in 40 of these 43 patients. Asthenia, arthralgia, associated extrahepatic diseases, Raynaud's phenomenon, and other antinuclear specificities were significantly less common, and titers of antimitochondrial antibodies were significantly lower in patients with antibodies directed to the 200-kilodalton polypeptide of the nuclear envelope than in patients without these antibodies. Clinical outcome, liver tests, and histological lesions did not significantly differ in patients with and without these antibodies.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007028451

Download citation: RISBibTeXText

PMID: 2188869


Related references

Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. Gastroenterology 99(1): 181-186, 1990

Characterization of the 200 kd polypeptide recognized by serum auto antibodies to nuclear envelope in primary biliary cirrhosis. Hepatology 12(4 PART 2): 956, 1990

Antinuclear envelope antibodies and primary biliary cirrhosis. Medicina Clinica 93(15): 596-597, 1989

Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. Journal of Autoimmunity 20(3): 247-254, 2003

A male patient who developed late-onset primary biliary cirrhosis presenting with antinuclear envelope antibodies. Modern Rheumatology 12(3): 246-249, 2002

Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clinical and Experimental Immunology 74(2): 283-288, 1988

Multiple nuclear dots antinuclear antibodies are not specific of primary biliary cirrhosis. Gastroenterology 100(5 PART 2): A784, 1991

Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis. Hepatology 16(1): 127-131, 1992

The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. Journal of Clinical Investigation 86(1): 279-285, 1990

Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis. Hepato-Gastroenterology 43(11): 1135-1140, 1996

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. American Journal of Gastroenterology 98(2): 431-437, 2003

Multiple nuclear dots antinuclear antibodies of primary biliary cirrhosis pbc react with 78 92kd and 96 100kd proteins of nuclear bodies. Journal of Hepatology 11(SUPPL 2): S88, 1990

Multiple nuclear dot antinuclear antibody in patients without primary biliary cirrhosis. Indian Journal of Biochemistry and Biophysics 35(1): 41-47, 1998

Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. American Journal of Gastroenterology 99(4): 763-4; Author Reply 765, 2004

Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly. Clinical and Experimental Immunology 136(3): 568-573, 2004